Examination of Left Atrial Fibrosis Using MRI
Withdrawn
- Conditions
- Fibrosis
- Registration Number
- NCT01233674
- Lead Sponsor
- University of Pittsburgh
- Brief Summary
This study evaluates images obtained from a standard clinical cardiac MRI for evidence of fibrosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- 18+ years of age
- being scheduled for a standard of care MRI
Exclusion Criteria
- patient unable to provide informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie left atrial fibrosis detected by cardiac MRI in NCT01233674?
Are there specific biomarkers associated with left atrial fibrosis progression in cardiovascular diseases?
How does left atrial fibrosis observed in MRI correlate with clinical outcomes in atrial fibrillation patients?
What are the potential adverse events linked to left atrial fibrosis and how can they be managed?
What role do collagen deposition and fibroblast activation play in left atrial fibrosis studied in NCT01233674?
Trial Locations
- Locations (1)
UPMC CVI
🇺🇸Pittsburgh, Pennsylvania, United States
UPMC CVI🇺🇸Pittsburgh, Pennsylvania, United States